GlassScriptPhysician profile
Benjamin Steven Crouch
NPI 1336302546
$5,823.89
in general payments reported to CMS, 2019-2025
27 companies · $870 in 2025
The $870 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $203 · 2021: $215 · 2022: $1,721 · 2023: $1,804 · 2024: $682 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,579 · Travel and Lodging: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,579.08 |
| Travel and Lodging | $777.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $2,298.10 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $1,087.29 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $661.66 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $528.41 | 2019-2023 | Spinejack |
| Amgen INC. | $191.11 | 2019-2025 | Evenity, Prolia, Prolia |
| Saluda Medical Americas, INC. | $147.90 | 2025 | Evoke |
| Radius Health, INC. | $105.93 | 2021-2023 | Tymlos |
| Medtronic USA, INC. | $96.44 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $86.79 | 2022-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.56 | 2022-2024 | Relistor |
| Averitas Pharma INC. | $79.23 | 2024-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $72.38 | 2025 | |
| Abbott Laboratories | $71.34 | 2019-2025 | Eterna, Proclaim |
| Orthofix Medical, INC. | $69.18 | 2025 | Physio-Stim |
| Painteq LLC | $40.02 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $25.59 | 2025 | Senza |
| Pfizer INC. | $24.38 | 2019 | |
| Arteriocyte Medical Systems, INC. | $22.00 | 2020 | |
| Grt US Holding, INC. | $16.71 | 2020 | |
| Bioventus LLC | $15.83 | 2019 | |
| Acell, INC. | $15.52 | 2019 | |
| Biodelivery Sciences International, INC. | $14.62 | 2020 | |
| Curonix LLC | $14.59 | 2022 | |
| Spr Therapeutics, INC | $14.26 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $13.97 | 2020 | |
| Stimwave Technologies Incorporated | $13.32 | 2019 | |
| Kci USA, INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.